Toronto Blue Jays right‑hander Jose Berrios will undergo elbow surgery on May 22, 2026, as the club eyes a repeat MLB World Series appearance after last season’s run to the championship series. The procedure targets a stress fracture in the ulnar collateral ligament area and possible loose bodies, and the team expects Berrios to miss at least two months, with a longer timetable if damage proves more severe during the operation.
Blue Jays manager John Schneider confirmed the surgery Thursday, noting that Berrios has not thrown since a pre‑World Baseball Classic MRI revealed the fracture during Team Puerto Rico’s preparation for the international tournament. The loss leaves Toronto scrambling to re‑configure a rotation that powered a championship bid and now faces the gauntlet of the American League East, where the New York Yankees, Baltimore Orioles, and Boston Red Sox remain formidable obstacles to another pennant.
What does Berrios’ injury mean for Toronto’s recent World Series run?
Toronto reached the 2025 World Series on the strength of a deep bullpen and a five‑game winning streak in the ALCS, erasing a 2‑0 deficit against the Kansas City Royals to advance. However, Berrios never took the mound in the postseason after landing on the injured list in September with what was initially described as forearm fatigue. The diagnosis of a stress fracture explains the lingering discomfort that prevented the Puerto Rican native from contributing during the championship push.
Berrios, acquired by the Blue Jays in a 2021 trade with the Minnesota Twins, has been a model of consistency in Toronto’s rotation. The 30‑year‑old posted a 3.45 ERA and 1.12 WHIP in 2024, ranking in the top 20 for strikeout rate among qualified starters before the injury. His ability to pitch deep into games—averaging 6.2 innings per start—provided the Blue Jays with the length necessary to preserve a bullpen that logged a league‑fourth 3.42 ERA in the first half of 2026.
How severe is the elbow damage and what is the recovery outlook?
The surgery will address a stress fracture in the ulnar collateral ligament area and remove any loose fragments that could impair velocity or cause further structural damage. Schneider warned that “if the damage is more significant, the timeline could be even longer,” suggesting a possible return in late August at the earliest if the procedure reveals only minor fraying. The club will likely place Berrios on the 60‑day injured list, opening a roster spot for a call‑up from Triple‑A Buffalo.
Medical experts note that stress fractures in the UCL region differ from complete tears requiring Tommy John surgery. While UCL reconstructions typically require 12‑18 months of rehabilitation, a targeted repair for a stress fracture can allow pitchers to return within 2‑4 months if no graft is necessary. However, the Blue Jays’ cautious approach reflects lessons learned from similar injuries across the league—rushing a pitcher back from elbow trauma often leads to setbacks that prove more costly in the long run.
Key Developments
- Blue Jays announced the surgery via a press release on May 16, 2026.
- Medical staff expect a minimum two‑month recovery, but a more extensive repair could extend the timeline well into September.
- Toronto’s rotation will shift to a three‑starter core with veteran Chris Sale slated to start the next series.
- Berrios posted a 3.45 ERA and 1.12 WHIP in 2024, ranking in the top 20 for strikeout rate before the injury.
- The Blue Jays will add a left‑handed reliever from Triple‑A Buffalo to fill the bullpen gap created by Berrios’ absence.
- Toronto finished the 2025 regular season with a 94‑68 record, clinching the AL East on the final weekend and posting a league‑best ERA of 3.21 (general knowledge).
What’s next for the Blue Jays and their MLB World Series aspirations?
Toronto must rely on emerging talent like rookie pitcher Nate Pearson and veteran ace Kevin Gausman to sustain momentum through the summer schedule. If Berrios returns by August, the club could still field a five‑starter rotation for a September push, but the front office admits the window narrows without his veteran presence. The situation underscores how health, not just talent, often decides who hoists the championship trophy.
Chris Sale, a 34‑year‑old left‑hander acquired in the off‑season from the Atlanta Braves, is set to anchor the rotation while the club evaluates internal options. Sale posted a 2.87 ERA in his first three starts this season, and his veteran poise could buy the Jays time to develop Pearson, who logged 78 strikeouts in 62 innings last year. The numbers reveal that a solid fifth starter can lower a team’s team ERA by roughly 0.15 runs per game, a margin that often separates playoff teams in a tight AL East race where every game carries postseason implications.
Gausman, the staff ace who signed a five‑year, $110 million extension last winter, carries the heaviest burden. The 32‑year‑old right‑hander logged a 3.12 ERA in 2025 and served as the workhorse during the postseason, making three starts in the ALCS and World Series. His ability to pitch deep into games becomes even more critical with Berrios sidelined, as the Blue Jays cannot afford to tax a bullpen that will be asked to cover more innings than originally planned.
The Blue Jays’ depth will be tested against a division that features the Yankees’ potent lineup led by Aaron Judge and Juan Soto, the Orioles’ young core headlined by Adley Rutschman, and a Red Sox team that added significant talent in the off‑season. Toronto’s 94‑68 record from 2025 (general knowledge) won’t be easy to replicate without its full rotation intact, but the organization believes the pieces are in place to remain competitive.
According to ESPN, Toronto’s bullpen logged a 3.42 ERA in the first half of 2026, ranking fourth in the league. Adding a fresh arm from Triple‑A could keep that metric steady despite Berrios’ absence. The Bisons’ left‑hander, whose name was not disclosed, will provide a different look against right‑heavy lineups in the AL East, where matchup versatility often determines late‑inning success.
Historical precedent offers both caution and hope. The 2019 Washington Nationals lost starter Max Scherzer to a finger injury late in the season but rallied behind their depth to capture the World Series. Conversely, the 2022 Mets saw their championship hopes evaporate when starter Jacob deGrom underwent season‑ending elbow surgery, illustrating how a single injury can alter a franchise’s trajectory. The Blue Jays, aware of both possibilities, are proceeding with measured optimism while preparing for every outcome.
The next six weeks will define Toronto’s season. If Pearson emerges as a reliable fourth starter and Sale maintains his early‑season dominance, the Blue Jays can weather the storm and position themselves for a late‑season push. If the young arms struggle and the bullpen wears down, the front office may need to explore the trade market for starting pitching, though the cost of mid‑season acquisitions typically exceeds fair value. For now, the focus remains on Berrios’ recovery and giving the remaining rotation every opportunity to succeed.
When did Jose Berrios last pitch in the World Series?
Berrios never appeared in the 2025 World Series; he was sidelined after a stress fracture was diagnosed during the pre‑tournament MRI for the World Baseball Classic, which explained the forearm discomfort that plagued him throughout September.
What are typical recovery times for elbow surgery on a pitcher?
Most pitchers return between 6 and 9 months after ulnar collateral ligament surgery, but a stress‑fracture repair like Berrios’ often sees a 2‑ to 4‑month timeline if no graft is required. The variance depends on the severity of the damage found during the procedure.
How did the Blue Jays perform in the regular season leading up to their World Series run?
Toronto finished the 2025 regular season with a 94‑68 record, clinching the AL East on the final weekend and posting a league‑best ERA of 3.21, a key factor in their postseason success (general knowledge). The rotation’s dominance carried over to October, where the bullpen logged a 2.89 ERA across 12 postseason games.